We are live on ! Find out more
ONCO icon

Onconetix
ONCO

5 hedge funds and large institutions have $43K invested in Onconetix in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more capital invested

Capital invested by funds: $26.7K → $43K (+$16.3K)

0.03% more ownership

Funds ownership: 0% → 0.03% (+0.03%)

50% less funds holding

Funds holding: 10 → 5 (-5)

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

Holders
5
Holders Change
-5
Holders Change %
-50%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$34.1K
2
UBS Group
UBS Group
Switzerland
+$16.1K
3
TRCT
Tower Research Capital (TRC)
New York
+$1.47K
4
SS
SBI Securities
Japan
+$294

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$11K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$5.27K
3
AFG
American Financial Group
Ohio
-$2.81K
4
SRL
Scientech Research LLC
New Jersey
-$2.33K
5
VF
Virtu Financial
New York
-$2K

ONCO Hedge Fund Activity: Q2 2025 in Review

5 of the 7,610 institutional investors tracked by Wall St. Rank reported a position in Onconetix (ONCO) for Q2 2025, worth a combined $43K — up 61% from $26.7K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ONCO and 2 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $34.1K. The largest seller was HRT Financial, exiting entirely with an estimated $11K sold.

  • 5 institutional investors held Onconetix (ONCO) as of Q2 2025, down from 10 in Q1 2025.
  • Funds reported $43K of Onconetix stock for Q2 2025, up 61% quarter-over-quarter.
  • 2 funds opened new Onconetix positions in Q2 2025 and 7 closed out, a net change of -5 holders.
  • The largest Onconetix buyer in Q2 2025 was Morgan Stanley, an estimated $34.1K added.
  • The largest Onconetix seller in Q2 2025 was HRT Financial, an estimated $11K sold.

Based on aggregated 13F filings for Q2 2025.